These enzymes—in conjunction with the release of IL-8, tumor growth factor beta (TGF-β), and TNF-α–have been associated with angiogenesis trough vascular endothelial growth factor (VEGF) and MMP modulation in different breast cancer phenotypes (9, 84). Here, VEGFA is linked to breast carcinoma.